Nanlin Hu
Beijing, 100034, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Predictive factors for the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: a retrospective study.
Journal: Journal of thoracic disease
Published: April 29, 2025
Biotic and Abiotic Drivers of Ecosystem Temporal Stability in Herbaceous Wetlands in China.
Journal: Global change biology
Published: June 23, 2024
Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq.
Journal: Cancer immunology, immunotherapy : CII
Published: May 20, 2024
Smell cancer by machine learning-assisted peptide/MXene bioelectronic array.
Journal: Biosensors & bioelectronics
Published: April 10, 2024
Soil microbial abundance was more affected by soil depth than the altitude in peatlands.
Journal: Frontiers in microbiology
Published: October 13, 2022
Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy.
Journal: Current cancer drug targets
Published: September 30, 2021
Decrease in the residents' accessibility of summer cooling services due to green space loss in Chinese cities.
Journal: Environment international
Published: August 11, 2021
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA.
Journal: Cancer biology & medicine
Published: May 26, 2021
Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer.
Journal: Cancer biology & medicine
Published: March 12, 2021
Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer.
Journal: Biomarker research
Published: January 11, 2021
Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
Journal: International journal of nanomedicine
Published: December 17, 2020
Last Updated: 09/26/2026